STC314
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STC314, covering 2024-08-12 to 2024-08-12. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Dose Exploration Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Characteristics of STC314 Injection Administered Intravenously in Sepsis Patients [Phase 2]